#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hereditary spastic paraplegia Krabbe's disease Gastrointestinal neuroendocrine tumour Neurodermatitis Still's disease Cognitive disorder Cervix carcinoma recurrent Malignant oligodendroglioma Small cell lung cancer Amyotrophic lateral sclerosis gene carrier Arteriovenous malformation Mitochondrial encephalomyopathy Leiomyosarcoma metastatic Hyperadrenocorticism Haematological malignancy More trials…

    Learn about Rare Diseases

    Hypereosinophilic syndrome Sarcoma – Treatment Lymphangiosarcoma – Treatment Rett syndrome – Life with Disease Pulmonary sarcoidosis – Treatment Cholangitis sclerosing – Trials in Disease Chondrosarcoma metastatic – Diagnostics Idiopathic inflammatory myopathy Atypical teratoid/rhabdoid tumour of CNS – Treatment Progressive supranuclear palsy – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Pehero SODIUM FUSIDATE Gs-1427 Threonine F510/08 Prednisone Acetate Cilgavimab Tolebrutinib Aclidinium Bromide Befiradol (18F) Elezanumab Tretinoin VOROLANIB Sodium Hyaluronate Msv-Allo Pivmecillinam Hydrochloride Nelivaptan GSKVX000000044501 Dostarlimab Intestifix More therapies…

    Learn about Your Condition

    Hereditary optic atrophy Skin disorder Prostate cancer metastatic Hepatic encephalopathy Nephrotic syndrome Melanoma recurrent Aortic aneurysm Prolymphocytic leukaemia Pulmonary vascular disorder Hypersomnia Clostridium difficile colitis Bone sarcoma Sarcoma Familial mediterranean fever Angiopathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • A Phase 3 Study of Delgocitinib Cream to Evaluate Efficacy and Safety in Adult Women with Lichen Sclerosus

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Lichen sclerosus
    France Germany Italy Poland Spain

  • Capecitabine drug combination in perioperative treatment for patients with gastric and esophageal cancer

    Not yet recruiting

    1 1 1 1
    Investigated Diseases:
    • Gastric cancer
    • Oesophageal carcinoma
    Investigated Drugs:
    • Capecitabine
    The Netherlands

  • Efficacy and Safety of ALKS 2680 and Alixorexton in Adults with Narcolepsy Type 1

    Not yet recruiting

    3 1
    Investigated Drugs:
    • Alks 2680
    Austria Belgium Finland France Germany Italy +5

  • Study of Doxycycline Bone and Joint Penetration in Patients Undergoing Total Hip Arthroplasty for Hip Osteoarthritis

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Hip arthroplasty
    Investigated Drugs:
    • Doxycycline Monohydrate
    • Doxycycline
    France

  • Safety and Tolerability of PTI5803 in Patients Aged 14 Years and Older With Drug‑Resistant Seizures Due to Focal Cortical Dysplasia

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Epilepsy
    France

  • Evaluation of belantamab mafodotin plus drug combination in adult patients with newly diagnosed light chain amyloidosis

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Amyloidosis
    Investigated Drugs:
    • GSK5764227
    • Bortezomib
    • Cyclophosphamide
    Greece Italy Spain
Previous Page
1 … 675 676 677 678 679 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!